Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
Magellan Midstream Partners, L.P. and Plains All American Pipeline, L.P. have formed Saddlehorn Pipeline Company, a 50/50 limited liability company, to construct, own and operate the Saddlehorn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results